The gut lactic acid bacteria metabolite, 10-oxo-cis-6,trans-11-octadecadienoic acid, suppresses inflammatory bowel disease in mice by modulating the NRF2 pathway and GPCR-signaling
M. Ando, K. Nagata, R. Takeshita, N. Ito, S. Noguchi, N. Minamikawa, N. Kodama, A. Yamamoto, T. Yashiro, M. Hachisu, G. Ichihara, S. Kishino, M. Yamamoto, J. Ogawa, C. Nishiyama
This study identifies 10-oxo-cis-6,trans-11-octadecadienoic acid as an anti-inflammatory metabolite that suppresses colitis in mice via NRF2 pathway activation and GPCR signaling.
bioRxiv · Feb 22, 2023Immunology